A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
NCT02761616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76
Last updated 2017-02-01
Summary
This is a retrospective, and observational cohort study to determine the proportion of breast cancer first relapses, that are biopsied. The duration of the study will be approximately 24 months.
Conditions
Interventions
- OTHER
-
eBC treated participants
No intervention administered in this retrospective observational study.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- Argentina
Study Locations
More Related Trials
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer
NCT03000764 ·Status: COMPLETED ·Phase: NA
-
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
NCT04371913 ·Status: RECRUITING ·Phase: NA
-
Prospective Breast Cancer Biospecimen Collection
NCT04074720 ·Status: RECRUITING
-
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions
NCT02523612 ·Status: COMPLETED ·Phase: NA
-
Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants
NCT05054010 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Signature for Breast Cancer
NCT05724407 ·Status: UNKNOWN
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
NCT04480814 ·Status: COMPLETED
-
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study
NCT03078036 ·Status: COMPLETED
-
Follow-up in Early and Locally Advanced Breast Cancer Patients
NCT03859453 ·Status: COMPLETED
-
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
NCT03007641 ·Status: COMPLETED ·Phase: NA
-
Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy
NCT05951699 ·Status: RECRUITING
-
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING
-
Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy
NCT02027818 ·Status: COMPLETED ·Phase: PHASE2
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors
NCT01627366 ·Status: COMPLETED ·Phase: NA
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
Locoregional Recurrence of Breast Cancer
NCT05988112 ·Status: NOT_YET_RECRUITING
-
Recurrence Risk Evaluation by 21-gene Detection
NCT03841266 ·Status: COMPLETED
-
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
NCT02732171 ·Status: RECRUITING ·Phase: NA
-
Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer
NCT04781062 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
NCT06807502 ·Status: RECRUITING ·Phase: NA
-
Bone Marrow Micrometastases in Patients With Early Stage Breast Cancer
NCT02921152 ·Status: UNKNOWN ·Phase: NA